Literature DB >> 20520886

A DFT study of the reactivity of actinidocenes (U, Np and Pu) with pyridine and pyridine N-oxide derivatives.

Ludovic Castro1, Ahmed Yahia, Laurent Maron.   

Abstract

The ortho C-H bond activation of several pyridine and pyridine N-oxide derivatives mediated by Cp(2)An(IV)(CH(3))(2) and Cp(2)An(III)(CH(3)) (Cp = C(5)H(5) and An = U, Np, Pu) have been investigated at the DFT level. For uranium(IV) complex, an excellent agreement with experimental observations is found, and particularly in the case of 2-picoline where only ortho sp(2) C-H activation is observed without any sp(3) C-H activation. These differences of reactivity can be explained by the charges distribution at the metathesis transition state level. A predictive study of the reactivity of neptunium and plutonium complexes with pyridine and pyridine N-oxide is reported. This study shows that neptunium and plutonium have almost the same reactivity. The C-H activation mediated by actinide (III) complexes have found to be more kinetically and thermodynamically favorable than for actinide (IV) complexes. The influence of 5f electrons on organoactinide reactivity is found to be small by comparing implicit and explicit treatment of 5f electrons.

Entities:  

Year:  2010        PMID: 20520886     DOI: 10.1039/c002576c

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  2 in total

1.  Incipient class II mixed valency in a plutonium solid-state compound.

Authors:  Samantha K Cary; Shane S Galley; Matthew L Marsh; David L Hobart; Ryan E Baumbach; Justin N Cross; Jared T Stritzinger; Matthew J Polinski; Laurent Maron; Thomas E Albrecht-Schmitt
Journal:  Nat Chem       Date:  2017-05-08       Impact factor: 24.427

2.  A Structurally Characterized Organometallic Plutonium(IV) Complex.

Authors:  Christos Apostolidis; Olaf Walter; Jochen Vogt; Phil Liebing; Laurent Maron; Frank T Edelmann
Journal:  Angew Chem Int Ed Engl       Date:  2017-03-30       Impact factor: 15.336

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.